Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 129 results for "sarabjit kour nangra"

Halol contributes 35-40% to Sun's US sales: Angel Broking

Speaking to CNBC-TV18 on the impact of the surprise audit on the company, Sarabjit Kour Nangra, Angel Broking advises investors not to panic and wait till the details of the audit report are released. According to Nangra, Sun's merger with Ranbaxy ..., 1 month ago

'Accumulate' Cipla with target at Rs 480: Angel Broking

Angel Broking has maintained 'Accumulate' on Cipla with target price of Rs 480 in its report. Commenting on the result, Sarabjit Kour Nangra, VP Research, pharma, Angel Broking , said, ''1QFY2015 results for the company came below expectations. For the ...
 Myiris2 months ago
Business Standard India

Foreign investors accumulate Ranbaxy shares

Foreign institutional investors over the year — September to September — have increased their stake in Ranbaxy Laboratories to 13.08 per cent from 10.42 per cent, an increase of more than 1.1 crore shares. The mop-up has come in the back drop of ...
 Hindu Business Line19 hours ago Ranbaxy settles Texas health care litigation  Business Standard India2 weeks ago Ranbaxy to pay $40 mn to settle Texas Medicaid litigation  Business Standard India2 weeks ago Sun Pharma, Ranbaxy extends fall on US FDA's surprise plant inspection  Smart Investor1 month ago
DNA India

Angel Broking maintains Buy on Tech Mahindra

Tech Mahindra posted results marginally better than expected on the top line, while the net profit came in below expectations. On the top-line, the company posted USD revenues of USD 900 million V/s USD 890 million expected , posting a qoq growth of ...
 MyIris1 day ago Angel Broking maintains neutral on Ranbaxy Lab  MyIris3 days ago Angel Broking maintains Buy on United Phosphorus  MyIris1 week ago Angel Broking maintains Buy on HCL Tech  MyIris2 weeks ago

Tata Consultancy Q2 earnings misses estimates

October 30, 2014 Tata Consultancy Services Ltd, India's biggest software services exporter, posted a 13.6 percent rise in quarterly net profit, but missed analyst estimates on weakness in outsourcing demand in Latin America and in some ...
 Business Recorder2 days ago TCS profit misses analysts estimates  The Gulf Today2 weeks ago Tata Consultancy second-quarter earnings misses estimates ...  Reuters2 weeks ago TCS slumps over 8 percent, earnings miss estimates  Business Standard India2 weeks ago

Dr Reddy's July-Sept quarter net down 17% at Rs 574 crore

Indian drugmaker Dr Reddy's has faced a 17 per cent drop in its net profits in Q2 on a year-on-year basis. Depreciation of Ruble and the Ukrainian currency Hryvnia against the rupee along with not so satisfactory launches in the US market has led to ...
 Financial Chronicle2 days ago DRL Q2 Net down 17% at Rs 574.1 cr on muted growth in US  Business Standard India2 days ago
Business Standard India

Tech Mahindra posts in-line numbers in Q2FY15

Backed by strong growth in the US and better client mining, Tech Mahindra, country's fifth largest IT services company on Wednesday reported numbers mostly in line with the expectations in the Q2 of FY15. In the quarter ended September 30, 2014, the ...
 Business Standard India2 days ago Tech Mahindra to manage IT operations for Ahlstrom  Business Standard India1 month ago Angel Broking recommends 'Accumulate' on Tech Mahindra  MyIris1 month ago

Ranbaxy posts first profit in 6 quarters

NEW DELHI: Embattled drugmaker Ranbaxy Laboratories Ltd posted its first profit in six quarters on the back of the successful launch of Valsartan, the generic version of Swiss innovator Novartis' blockbuster blood pressure drug Diovan, in the US.
 Economic Times2 days ago Ranbaxy posts net profit of Rs478 crore  Livemint.com3 days ago Ranbaxy posts Rs478 crore profit in Q2; shares jump 6.11% [Mint, New Delhi :: ]  BusinessWeek3 days ago

Stocks shiver in market game but IT mood remains bullish

The stocks have fallen but that may hide some good news. India's IT sector seems to be back in the robust growth game despite recent market hiccups — if one looks beyond the obvious. On the one hand, three of the four top software service ...
 Hindustan Times1 week ago Stocks shiver in market game, but IT mood remains bullish [Hindustan Times, New Delhi :: ]  BusinessWeek1 week ago

Better luck next quarter

Sector review: IT After reporting subdued operating margins during the first quarter of this financial year, the IT industry was expected to perform slightly better for the period ended September 30. At the same time, most analysts were confident that the ...
 The Financial Chronicle1 week ago IT sector likely to see good revenue growth  Financial Chronicle3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less